Stocks and Investing Stocks and Investing
Tue, December 22, 2020
Mon, December 21, 2020
Sun, December 20, 2020
Fri, December 18, 2020

Tazeen Ahmad Maintained (SRPT) at Strong Buy and Held Target at $194 on, Dec 18th, 2020


Published on 2024-10-27 15:03:49 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $194 on, Dec 18th, 2020.

Tazeen has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Martin Auster of "Credit Suisse" Maintained at Hold with Decreased Target to $156 on, Monday, December 14th, 2020


These are the ratings of the 5 analyists that currently disagree with Tazeen


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $197 on, Friday, November 6th, 2020
  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020
  • Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $221 on, Monday, August 31st, 2020
  • Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $200 on, Tuesday, August 25th, 2020
Contributing Sources